Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3159-3166

  Barth, Rolf F ^a   Yang, Weilian ^a   Adams, Dianne M ^a   Rotaru, Joan H ^a   Shukla, Supriya ^b   Sekido, Masaru ^b   Tjarks, Werner ^b   Fenstermaker, Robert A ^c   Ciesielski, Michael ^c   Nawrocky, Marta M ^d   Coderre, Jeffrey A ^d  

^a Department of Pathology ^*  (United States)

^b College of Pharmacy ^*  (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE; BORON 10; EPIDERMAL GROWTH FACTOR RECEPTOR; IODINE 125;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DOSIMETRY; DRUG EFFICACY; GENETIC TRANSFECTION; GLIOMA; HUMAN; HUMAN CELL; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; EPIDERMAL GROWTH FACTOR; GLIOMA; HUMANS; RATS; RATS, INBRED F344; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 0036606584     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. The chemistry of neutron capture therapy
2. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality
3. The radiation biology of boron neutron capture therapy
4. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption
5. Boron neutron capture therapy of brain tumors: Enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine
6. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: Evaluation as a potential delivery system for neutron capture therapy
7. Critical evaluation of bi-specific antibodies as targeting agents for boron neutron capture therapy of brain tumors
8. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors
9. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors
10. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts
11. Patterns of epidermal growth factor receptor amplification in malignant gliomas
12. EGFR gene amplification-rearrangement in human glioblastoma
13. Diversity and frequency of epidermal growth factor receptor mutation in human glioblastomas
14. The EGF receptor family as targets for cancer therapy
15. The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia
16. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase
17. Malignant astrogliomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase 11 trial
18. A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas
19. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor
20. Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy
21. The effect of epidermal growth factor receptor (EGFR) expression on in vivo growth of rat C6 glioma cells
22. Rat brain tumor models in experimental neuro-oncology: The 9L, C6, T9, F98, RG2 (D74), RT-2, and CNS-I gliomas
23. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A43I epidermoid carcinoma cells
24. Retroviral vectors containing putative internal ribosome entry sites: Development of a polycistronic gene transfer system and applications to human gene therapy
25. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy
26. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption
27. Improved apparatus for neutron capture therapy of rat brain tumors
28. A beam-modification assembly for experimental neutron capture therapy of brain tumors
29. 7 Li irradiation of the brain vasculature
30. Boron neutron capture therapy of a rat glioma
31. Development of blood vessel-related radiation damage in the fimbria of the central nervous system
32. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Parts I and II
33. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning
34. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: Relevance to neutron capture therapy
35. Neutron capture therapy of intracerebral melanoma: Enhanced survival and cure following blood-brain barrier opening to improve delivery of boronophenylalanine
36. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity
37. Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics and radiation dosimetry of sodium borocaptate in glioma patients
38. Microdosimetry model for boron neutron capture therapy: I. Determination of microscopic quantities of heavy particles on a cellular scale
39. Evaluation of systemically administered radiolabeled epidermal growth factor as brain tumor targeting agent
40. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors
41. Monoclonal antibodies against EGFR vIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
42. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor. EGFR vIII
43. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor
44. Design of a novel small peptide targeted against a tumor-specific receptor
45. The type III epidermal growth factor receptor mutation
46. Growth factor receptors as molecular targets for cancer diagnosis and therapy
47. Epidermal growth factor receptor as a target: Recent developments in the search for effective new anti-cancer agents
48. A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptor
49. Epidermal growth factor receptor-targeted therapy with C 225 and cisplatin in patients with head and neck cancer
50. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability
51. Biological modifiers as potential radiosensitizers: Targeting the epidermal growth factor receptor family
52. Distribution of i. v. administered growth factor in the rat
53. 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy
54. Convection-enhanced delivery of macromolecules in the brain
55. Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time
56. Convection enhanced delivery of boronated epidermal growth factor to EGF receptor positive gliomas for neutron capture therapy
57. Targeting brain tumors via the EGF receptor: Comparison of anti-EGFR MoAbs and EGF based bioconjugates